Related Experiment Video

Updated: May 11, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2

Mario Acunzo1, Giulia Romano, Dario Palmieri

  • 1Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

Proceedings of the National Academy of Sciences of the United States of America
|May 8, 2013
PubMed

Insights

This study reveals that microRNA-27a (miR-27a) regulates key cancer-driving genes, epidermal growth factor receptor (EGFR) and MET, in lung cancer. This finding suggests a new therapeutic strategy targeting the miR-27a, EGFR, and MET pathway for lung cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer therapy has advanced with targeted treatments, but early detection and novel therapeutic strategies remain crucial.
  • Epidermal growth factor receptor (EGFR) and MET are cell-surface tyrosine kinases involved in tumor progression and miRNA regulation.
  • The miRNA cluster 23a ~ 27a ~ 24-2 plays a role in cellular processes relevant to cancer.

Purpose of the Study:

  • To elucidate the biological relationship between EGFR, MET, and the miRNA cluster 23a ~ 27a ~ 24-2 in lung cancer.
  • To investigate the regulatory role of miR-27a on EGFR, MET, and Sprouty2.
  • To identify mechanisms of miR-27a-mediated regulation of the EGFR and MET signaling axis.

Main Methods:

  • Investigated the biological link between EGFR, MET, and the miRNA cluster 23a ~ 27a ~ 24-2.
  • Assessed the regulatory effect of miR-27a on MET, EGFR, and Sprouty2 expression in lung cancer models.
  • Identified direct and indirect regulatory pathways of miR-27a on MET and EGFR.

Main Results:

  • Demonstrated a significant biological link between EGFR, MET, and the miRNA cluster 23a ~ 27a ~ 24-2.
  • Confirmed that miR-27a regulates MET, EGFR, and Sprouty2 in lung cancer.
  • Uncovered both direct and indirect mechanisms by which miR-27a influences MET and EGFR signaling.

Conclusions:

  • MiR-27a plays a critical role in regulating the EGFR and MET signaling axis in lung cancer.
  • The identified regulatory mechanism provides a potential target for developing novel lung cancer therapeutics.
  • Further research into the miR-27a, EGFR, and MET pathway could lead to improved patient outcomes.
Keywords:
cell signalingepigenetics

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...